Home Tags Sexually Transmitted Diseases: AIDS/HIV

Tag: Sexually Transmitted Diseases: AIDS/HIV

Guidelines Developed for Diabetes Management in CKD

Kidney Disease May Add to Higher Risk for CVD Due to HIV

The effect of HIV serostatus on brachial artery flow-mediated dilation strongly influenced by kidney function

WHO: Strawberry-Flavored HIV Medication Coming for Infants

WHO has also approved the dapivirine ring, a vaginal insert that has shown to be effective in protecting against HIV in women

Cabotegravir Injection Can Protect Women From HIV for Two Months

2010 to 2018 Saw Decrease in Rate of Death for People With HIV

48.4 percent decrease found in HIV-related death rates and 8.6 percent decrease seen in non-HIV-related death rate

Cabotegravir Injection Can Protect Women From HIV for Two Months

Experimental drug found to be 89 percent more effective at preventing HIV infection than Truvada pills

In a 2020 guideline from the International Antiviral Society-USA

Recommendations Updated for HIV Treatment, Prevention

Prompt initiation of antiretroviral therapy advised in those with HIV and detectable viremia
In a Society for Healthcare Epidemiology of America white paper

SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV

Career counseling recommended for those planning to conduct exposure-prone procedures
In a clinical report from the American Academy of Pediatrics

Guidelines Issued on Managing Infants Exposed to HIV

Counseling should be provided for parents, caregivers of infants exposed to HIV, including for routine care

September 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2020. This roundup includes...
Even among HIV-focused practitioners

PrEP Prescribing Low in the U.S., Even Among HIV Care Providers

About half of survey participants recruited from HIV CME courses reported ever prescribing PrEP
From 2014 to 2018

Insurer, Insured Costs for HIV PrEP Rising in the United States

2014 to 2018 saw increase in estimated third-party, out-of-pocket payments per 30 TDF-FTC tablets